When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OBSV - ObsEva up 26% premarket on positive data on linzagolix
ObsEva SA
ObsEva SA (NASDAQ:OBSV) is up 26% premarket on the heels of positive results from a Phase 3 PRIMROSE 2 trial evaluating linzagolix, including 100 mg and 200 mg doses, both with and without hormonal add-back therapy (ABT) for the treatment of heavy menstrual bleeding (HMB) due to uterine fibroids.
More news on: ObsEva SA, Healthcare stocks news, Stocks on the move,